Rocip Eye Drop is primarily indicated in conditions like Acromegaly (short-term treatment before pituitary surgery), Chronic prostatitis, Gl infections, Gonorrhoea, Iron-deficiency anaemia prophylaxis or for mild iron deficiency, Iron-deficiency anaemia with chronic renal failure, Most other infections, Muscle relaxation (long duration) for surgery and intubation, Muscle relaxation for surgery or intubation, Osteomyelitis, Pseudomonal lower RTI in cystic fibrosis, Respiratory tract infections, Sexually transmitted disease, Sexually transmitted infections, Skin infections, Skin structure infections, Status epilepticus (unlicensed use), Surgical prophylaxis, Urinary tract infection.
Rocip Eye Drop is contraindicated in conditions like Epilepsy,Hypersensitivity.
The severe or irreversible adverse effects of Rocip Eye Drop , which give rise to further complications include Pseudomembranous colitis, Hearing loss, Seizures.Rocip Eye Drop produces potentially life-threatening effects which include Anaphylactoid reactions, Stevens Johnson syndrome, Acute Renal Failure, Fluminant hepatic failure, Epidermal necrolysis. which are responsible for the discontinuation of Rocip Eye Drop therapy.The symptomatic adverse reactions produced by Rocip Eye Drop are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Diarrhea, Tachycardia, Nervousness, Termors, Rashes, Urticaria, Pruritus, Photosensitivity, Elevation of liver enzymes, Thrombocytopenia, Eosinophilia, Increased intracranial pressure, nervousness, joint symptoms, agranulocytosis.
Rocip Eye Drop should be used with caution in patients with known or suspected central nervous system (CNS) disorders, renal impairment or hepatic disease, with a history of GI disease especially colitis or who have dehydration. Do not exceed the recommended dose. Take appropriate measures if secondary infections occur.